Transcriptional Regulation in Eukaryotes

• Learning Objectives (LOs):

  • Describe the identification and purification processes for transcription factors (TFs).

  • Detail structural features, such as modularity and domains, that enable TFs to perform regulatory functions.

  • Classify the three primary motifs of DNA binding domains ($DBD$) used by TFs.

  • Analyze the recruitment and function of co-activators and co-repressors in modulating chromatin accessibility.

  • Summarize the multi-step enzymatic pathways for post-transcriptional modifications including capping, splicing, and polyadenylation.

Transcription Factors (TFs)

• Definition: Specialized proteins that bind to specific DNA sequences to control the rate of transcription from DNA to mRNA.

• Structural Complexity:

  • Composed of specific primary sequences of amino acids that fold into tertiary structures ($3D$) essential for chemical recognition of DNA.

  • Low Abundance: TFs are often expressed at very low levels, making their isolation and biochemical characterization difficult.

  • Functional Necessity: They determine cell-type specificity (e.g., why a neuron differs from a muscle cell) and allow cells to respond to environmental stimuli (e.g., heat shock or hormonal signals).

Identification and Isolation of Transcription Factors

• Bioinformatics Analysis: Modern genomic screening identifies conserved "consensus sequences" in the upstream promoter or distal enhancer regions ($5'$ UTR).

• DNA Affinity Chromatography:

  • Mechanism: A column is loaded with synthetic double-stranded DNA oligonucleotides containing the target binding site. Cellular extracts are passed through; only proteins with high affinity for that sequence bind, while others are washed away.

  • Historical Milestone: In 1986, Tijan identified Sp1 using this method. The protein was purified from HeLa cells, an immortalized cell line derived from Henrietta Lacks in 1951.

Structural Features and Domain Modularity

• Modular Construction: TFs are modular, meaning they have physically and functionally independent domains.

  • DNA-Binding Domain (DBD): Recognizes the specific DNA sequence.

  • Effector Domain (Activation/Repression): Interacts with the basal transcription machinery (RNA Pol II) or chromatin-modifying enzymes.

  • Dimerization Domain: Many TFs function as homo- or hetero-dimers to increase binding specificity.

Major Types of DNA Binding Domains

1. Zinc Fingers:

   • Structure: A loop of approximately $23$ amino acids stabilized by a $Zn^{2+}$ ion coordinated by Cysteine and Histidine residues (often $C<em>2H</em>2$ type).

   • Interaction: The alpha-helix insertion occurs in the major groove of the DNA. TFs like Sp1 contain multiple fingers to increase the footprint of DNA recognition.

2. Helix-Turn-Helix (H-T-H):

   • Structure: Two alpha-helices separated by a short turn. The "recognition helix" fits into the major groove.

   • Binding: Often bind as symmetric dimers to palindromic DNA sequences, spaced by roughly one full turn ($10.5$ base pairs) of the DNA helix.

3. Basic Binding Domains (bZIP and bHLH):

   • Leucine Zipper (bZIP): Characterized by a leucine residue at every $7^{th}$ position, creating a hydrophobic surface for dimerization. The "basic" region interacts with the negatively charged DNA backbone.

   • Example: C/EBP (CCAAT/Enhancer Binding Protein).

Mechanisms of Regulatory Action

• Activation through Chromatin Remodeling:

  • TFs recruit Co-activators such as p300/CBP, which possess Histone Acetyltransferase (HAT) activity.

  • Mechanism: Acetylation of lysine residues on histone tails neutralizes their positive charge, weakening the interaction between histones and DNA, leading to an "open" chromatin state (Euchromatin).

  • Example: The Glucocorticoid Receptor (GR) binds its ligand, translocates to the nucleus, and recruits HATs to initiate gene expression.

• Inhibition through Deacetylation:

  • TFs recruit Co-repressors like SMRT or NCoR, which recruit Histone Deacetylases (HDACs).

  • Mechanism: Removing acetyl groups restores the positive charge on histones, promoting a "closed" chromatin state (Heterochromatin) that prevents RNA Polymerase access.

Differences Between Prokaryotic and Eukaryotic Expression

• Prokaryotes: Coupled transcription and translation. No nuclear membrane barrier means ribosomes begin translating mRNA while it is still being synthesized.

• Eukaryotes: Spatial and temporal separation. Transcription occurs in the nucleus ($Transcription → Processing → Export$), and translation occurs in the cytoplasm. This allows for extensive post-transcriptional regulation.

Post-Transcriptional Modifications (mRNA Processing)

1. 5' Capping:

   • Structure: A $7 ‐ ext{methylguanosine}$ cap attached via a unique $5'-5'$ triphosphate bridge.

   • Enzymatic Steps:

     1. RNA triphosphatase removes the terminal phosphate from the nascent RNA.

     2. Guanylyltransferase adds GMP from GTP.

     3. Methyltransferase adds a methyl group to the Guanine at the $N^7$ position.

   • Function: Prevents degradation by exonucleases, assists in nuclear export, and is recognized by the ribosome for translation initiation.

2. RNA Splicing:

   • Mechanism: Conducted by the Spliceosome, removing non-coding introns and joining exons.

   • Conserved Sequences: The $5'$ splice site (typically $GU$) and the $3'$ splice site (typically $AG$), along with an internal Branch Point Adenine.

   • Reaction: Two successive transesterification reactions.

3. Polyadenylation:

   • Steps: Cleavage of the transcript downstream of the AAUAAA signal, followed by the addition of $≈ 200$ Adenine residues by Poly-A Polymerase (PAP).

   • Function: Increases mRNA half-life and aids in the circularization of mRNA for efficient translation.

Quality Control Mechanisms

• Capping Checkpoint: If an mRNA is incorrectly capped, it is degraded. In yeast, the Rai1-Rat1 complex performs this surveillance; in humans, the enzyme DXO decaps and degrades defective transcripts to ensure only functional mRNA reaches the cytoplasm.